Practice Location

601 5TH ST S
ST PETERSBURG, FL 33701-4804

Phone: (727) 767-4176

What does GREGORY HALE research?

Dr. Hale’s research primarily revolves around infectious diseases such as HIV, tuberculosis, and cryptococcal meningitis, exploring how these conditions can be better managed and diagnosed. He also investigates novel therapies for autoimmune disorders like rheumatoid arthritis and enhances understanding of diagnostic methods for rare diseases like Wilson disease. In addition, he studies the application of artificial intelligence and voice technology in healthcare, aiming to make diagnostics more accessible. His work helps reshape treatment protocols and improve patient care across various backgrounds.

Key findings

  • In HIV-associated meningitis survivors, 66% showed better cognitive function despite experiencing a condition called CSF HIV viral escape three months after treatment.
  • In a clinical trial, starting tuberculosis prevention therapy in the hospital resulted in 70% of advanced HIV patients remaining free from tuberculosis after 18 weeks, compared to 62% starting treatment post-discharge.
  • Dr. Hale's work shows that using a reduced dose of alemtuzumab in stem cell transplants could minimize side effects while maintaining safety and effectiveness.
  • In pediatric ADHD treatment, 11 out of 12 studies found that antidepressants had a role in reducing symptoms, offering alternative options to traditional stimulants.
  • The new urine test FujiLAM2 demonstrated 94% specificity in ruling out tuberculosis in patients with advanced HIV, although it only identified the disease in 34% of cases.

Frequently asked questions

Does Dr. Hale study HIV-related conditions?
Yes, Dr. Hale conducts research on HIV-associated meningitis and its effects on brain health.
What treatments has Dr. Hale researched for tuberculosis?
He has studied the effectiveness of initiating tuberculosis prevention therapy in the hospital for patients with advanced HIV.
Is Dr. Hale's work relevant to patients with rheumatoid arthritis?
Absolutely, he investigates new therapies that aim to improve the management and treatment of rheumatoid arthritis.
What innovative technologies does Dr. Hale use in his research?
He explores the application of voice analysis technology to improve health diagnostics and patient care.
Can Dr. Hale's research help patients with rare diseases?
Yes, his studies include developing sensitive tests for diagnosing conditions like Wilson disease.

Publications in plain English

Dose de-escalation of alemtuzumab in matched unrelated donor haematopoietic stem cell transplantation.

2026

British journal of haematology

Madkhali MM, Mitchell A, Wright C, Pearce K, Aku S +10 more

Plain English
This study looked at using a lower dose (30 mg) of the drug alemtuzumab to help with a specific type of stem cell transplant from unrelated donors. Researchers found that this single, reduced dose was safe and effective in removing certain immune cells during the transplant process. This is important because it could lead to fewer side effects and a simpler treatment for patients undergoing these transplants. Who this helps: Patients receiving stem cell transplants from unrelated donors.

PubMed

Inpatient initiation of tuberculosis preventive therapy with 1 month of isoniazid and rifapentine for adults with advanced HIV disease and cryptococcal meningitis (IMPROVE): a non-inferiority, randomised controlled trial.

2026

The lancet. HIV

Ellis J, Hale G, Nsangi LJ, Wele A, Kigozi E +18 more

Plain English
This study examined how starting a short course of tuberculosis prevention treatment in the hospital benefits adults with advanced HIV and a serious brain infection called cryptococcal meningitis. Researchers found that 70% of patients who began treatment before leaving the hospital remained free of tuberculosis after 18 weeks, compared to 62% who started treatment after going home. This is important because it shows that initiating treatment in the hospital is just as safe and effective as starting it later, which could lead to better health outcomes for vulnerable patients. Who this helps: Patients with advanced HIV and cryptococcal meningitis.

PubMed

Prevalence of CSF HIV VIRAL Escape and Associations With Neurocognitive Outcomes Among HIV-Associated Meningitis Survivors: A Cohort Study.

2026

Open forum infectious diseases

Nsangi L, Hale G, Dai B, Hullsiek KH, Tukundane A +13 more

Plain English
This study looked at 93 adults in Uganda who survived meningitis related to HIV. Researchers found that a common condition called "CSF HIV viral escape" happened frequently among these patients, and interestingly, those who had this condition showed better brain function three months later. This information is important because it helps understand how viral behavior in the body affects recovery and overall health. Who this helps: This helps patients recovering from HIV-associated meningitis and their doctors.

PubMed

Translating AI research into reality: summary of the 2025 voice AI Symposium and Hackathon.

2026

Frontiers in digital health

Salvi Cruz S, Toghranegar J, Malin B, Mehra T, MacDonald B +50 more

Plain English
The 2025 Voice AI Symposium focused on how to turn research about using voice analysis into practical healthcare tools. Experts discussed how voice technology can help detect health issues related to the brain, heart, and mental health, emphasizing the need for ethical practices when handling data. The event highlighted that voice analysis could become a key part of healthcare, making it more accessible and efficient. Who this helps: This benefits patients and healthcare providers looking for innovative diagnostics.

PubMed

Validation of Metallothionein Immunohistochemistry as a Highly Sensitive Screening Test for Wilson Disease.

2025

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Stokes NL, Patil A, Adeyi O, Bhalla A, Brown I +29 more

Plain English
This study examined a diagnostic test using metallothionein (MTH) immunohistochemistry to detect Wilson disease (WD), a rare genetic condition. The researchers analyzed 91 patients diagnosed with WD and found that 83 of them tested positive for the MTH marker, resulting in a test sensitivity of 91.2% and a specificity of 100%. These results indicate that MTH immunohistochemistry is a highly effective and reliable method for screening WD, making it a valuable tool for doctors in diagnosing this condition. Who this helps: This helps doctors and patients who are being evaluated for Wilson disease.

PubMed

British Association of Dermatologists living guideline for managing people with alopecia areata 2024.

2025

The British journal of dermatology

Harries MJ, Ascott A, Asfour L, Farrant P, Hale G +13 more

PubMed

Sotatercept: The First FDA-Approved Activin A Receptor IIA Inhibitor Used in the Management of Pulmonary Arterial Hypertension.

2025

American journal of cardiovascular drugs : drugs, devices, and other interventions

Villanueva J, Wade J, Torres A, Hale G, Pham H

Plain English
This study focuses on sotatercept, a new medication approved by the FDA for treating pulmonary arterial hypertension (PAH), a condition that affects blood flow in the lungs. In clinical trials, patients taking sotatercept could walk an average of 40.1 meters further in six minutes compared to those on a placebo, who actually walked 1.4 meters less. This is important because it shows that sotatercept can help improve patients' physical abilities and potentially reduce serious health risks related to PAH. Who this helps: This benefits adults living with pulmonary arterial hypertension.

PubMed

Impact of a Managed Care Elective on Pharmacy students' Confidence Performing Transitions of Care via Telehealth.

2025

Currents in pharmacy teaching & learning

Gangoo-Dookhan T, Hale G, Seamon M, Lopez NA, Belcher S +2 more

Plain English
This study looked at how a new elective course about managed care affected pharmacy students' confidence and understanding of providing care through telehealth, especially during transitions of care. After taking the course, students reported a significant increase in their confidence in performing these services, as shown by improvements on a survey measuring their knowledge. Additionally, only 11.8% of patients who received support from these students were readmitted to the hospital within 30 days, which is better than the national average. Who this helps: This benefits pharmacy students and their future patients by equipping students with essential skills for modern healthcare.

PubMed

Adequacy of recommendations for adverse event management in national and international treatment guidelines for rifampicin-susceptible tuberculosis: a systematic review.

2025

EClinicalMedicine

Burman W, Ellis J, Hale G, Hill K

Plain English
This study reviewed treatment guidelines for tuberculosis to see how well they address the side effects patients may experience during treatment. They found that out of 47 guidelines, 37 (or 79%) offered recommendations for managing side effects like nausea and skin reactions. However, many international guidelines were lacking in this area, meaning patients might not get the best support during treatment. Who this helps: This benefits tuberculosis patients and their healthcare providers.

PubMed

Diagnostic accuracy of the re-engineered urinary FujiLAM2 assay amongst hospitalized adults with advanced HIV disease.

2025

AIDS (London, England)

Ellis J, Dai B, Kabahubya M, Hale G, Mande E +12 more

Plain English
Researchers studied a new urine test called FujiLAM2 to see how well it can diagnose tuberculosis (TB) in hospitalized adults with severe HIV. They tested 436 patients and found that the FujiLAM2 test correctly identified TB in only 34% of cases (sensitivity), but it was accurate in ruling out TB in 94% of those who did not have the disease (specificity). This matters because an effective quick test could help reduce TB-related deaths in people who are already very ill with HIV. Who this helps: This helps patients with advanced HIV disease who are at risk for TB.

PubMed

Pace of adoption of alternatives to animal-source foods is an important factor in reaching climate goals.

2025

Scientific reports

Hale G, Oncescu V, Bhangale R

Plain English
The study examined how quickly we can shift from eating animal-based foods to alternative options, like plant-based diets, to help reduce greenhouse gas emissions and meet climate goals. It found that if we adopt these alternatives quickly, we can still meet global demands for food without significantly increasing emissions. However, if we wait too long to make this change, we will need to cut down even more on animal products by 2050 to stay within safe limits for carbon emissions. Who this helps: This benefits everyone, especially those focused on climate change, food security, and health.

PubMed

The efficacy and safety of antidepressants as alternative treatment of attention-deficit/hyperactivity disorder in pediatric populations.

2025

The mental health clinician

Hilo S, Hale G, Pham H, Khanfar N

Plain English
This study looked at whether antidepressants can effectively treat attention-deficit/hyperactivity disorder (ADHD) in children and teens. Out of 12 studies reviewed, 11 found that antidepressants helped reduce ADHD symptoms, but they weren't necessarily better than the usual stimulant treatments. Understanding alternative treatments is important because it could provide safer options for patients who might be at risk of side effects or misuse from stimulants. Who this helps: This research benefits children and adolescents with ADHD who may require alternative treatment options.

PubMed

A phase 1 experimental medicine study of anti-CD3 monoclonal antibody in rheumatoid arthritis.

2025

Immunotherapy advances

Lawson CA, Harry R, Griffiths B, Hale G, Waldmann H +1 more

Plain English
This study looked at a new drug called otelixizumab to see how safe it is for people with rheumatoid arthritis (RA). Six participants experienced a moderate reaction after the first dose, which included a temporary drop in certain immune cells but no lasting harm. Those who continued treatment showed a lasting decrease in a marker of inflammation, which is a positive sign. Who this helps: Patients with rheumatoid arthritis.

PubMed

Evaluating Pharmacist-Driven Interventions in a Primary Care Setting to Improve Proportion of Days Covered and Medication Adherence.

2024

Journal of pharmacy practice

Davis DD, Hale G, Moreau C, Joseph T, Perez A +1 more

Plain English
This study looked at how pharmacists in primary care can help patients stick to their medication schedules, focusing on heart and diabetes medications. It found that patients on medications like ACE inhibitors and statins experienced a significant increase in their adherence scores after receiving help from pharmacists, with scores going up from 72.5 to 78.0 for ACE inhibitors and from 73.3 to 76.6 for statins. This is important because better medication adherence can lead to improved health outcomes and fewer hospital visits for patients. Who this helps: Patients who need assistance managing their medications.

PubMed

Fouling of virus filtration membranes by monoclonal antibody feeds with low aggregate content.

2024

Biotechnology and bioengineering

Kaufman Y, Hunt KC, Hale G, McClure M, Latulippe D +6 more

Plain English
This study looked at how certain monoclonal antibodies (mAbs) can clog virus filtration membranes, which is a key problem in purifying these antibodies. They found that some mAbs caused a significant decrease in the membrane's ability to filter, with some reducing its effectiveness by over 90% even after pre-filtering, while others only decreased it by around 10%. Understanding why some mAbs foul membranes more than others is crucial because it can help create better filters for purifying medicines. Who this helps: This benefits patients by improving the manufacturing processes of therapies that use monoclonal antibodies.

PubMed

Use trends of chlorthalidone and hydrochlorothiazide among United States adults with hypertension: National Health and Nutrition Examination Survey 2009-2018.

2024

Journal of hypertension

Hale G, Puchades E, Jacomino G, El-Mcharfie L, Perez A

Plain English
This study looked at how many adults in the U.S. with high blood pressure were using two different medications: chlorthalidone and hydrochlorothiazide. Out of 2,585 participants, 95.2% were taking hydrochlorothiazide, while only 4.8% were using chlorthalidone. The results showed that people over 65 and those with specific health problems (low potassium or sodium levels) were more likely to be prescribed chlorthalidone, which is an effective treatment that is not used as much as it should be. Who this helps: This helps patients with hypertension, especially older adults and those with certain medical conditions.

PubMed

Real-World Analysis of Long-Acting and NPH-Containing Insulins on Glycemic Control.

2024

The Senior care pharmacist

Hale G, Marcellus V, Benny T, Moreau C, Rosario E +1 more

Plain English
This study looked at the effects of two types of insulin—lower-cost NPH-containing insulins and higher-cost long-acting insulins—on patients with type 2 diabetes covered by Medicare. It found that only 3.5% of patients using long-acting insulin experienced severe hypoglycemia (dangerously low blood sugar levels), while none using NPH did, and there was no significant difference in mild hypoglycemic episodes or overall blood sugar control. This matters because it suggests that patients can safely use more affordable NPH insulins without a higher risk of severe complications. Who this helps: Patients who need insulin, especially those looking for affordable treatment options.

PubMed

Factors that affect powered wheelchair use for an adult population: a systematic review.

2024

Disability and rehabilitation. Assistive technology

Fishleigh L, Taylor R, Hale G, Bowers DS

Plain English
This review looked at the various factors that influence how adults with disabilities use powered wheelchairs. It analyzed 15 studies and found that the use of powered wheelchairs depends on multiple interconnected elements, such as how well individuals adjust, cooperation among involved parties, societal attitudes, personal abilities, and environmental conditions. Understanding these factors is important for improving how powered wheelchairs are prescribed and provided to those who need them. Who this helps: This helps patients who use powered wheelchairs and the doctors who prescribe them.

PubMed

Earthquakes, Hurricanes, Pandemics: Pharmacy Students Impacting Pharmacy Practice in Puerto Rico Through Medication Therapy Management Services During Disasters.

2024

Disaster medicine and public health preparedness

Arce L, Hale G, Khanfar N, Pérez Ayala N, Aponte Torres G +1 more

Plain English
This study looked at how pharmacy students in Puerto Rico perceived their experiences providing medication management services during disasters like hurricanes, earthquakes, and pandemics. Sixteen students completed a survey, and most agreed that their training helped them learn important skills to support patients and communities affected by these disasters. This is important because it highlights the crucial role pharmacists play in healthcare during emergencies and suggests that disaster response training should be included in pharmacy education. Who this helps: This benefits pharmacy students and communities impacted by disasters.

PubMed

Lend a helping hand: Mentoring through chaos.

2024

Nursing management

Hedenstrom ML, Toney S, Knotts K, Talton E, Ndungu J +5 more

PubMed

Canopeo app as image-based phenotyping tool in controlled environment utilizing Arabidopsis mutants.

2024

PloS one

Hale G, Yuan N, Mendu L, Ritchie G, Mendu V

Plain English
This study looked at how well the Canopeo app can be used to measure the growth of different mutant plants called Arabidopsis thaliana. Researchers found that one mutant plant with less FKF1 gene activity (called fkf1-t) grew better under certain conditions, showing increased biomass and better seedling health, while another mutant with more FKF1 activity (FKF1-OE) mainly focused on producing seeds instead of growing leaves. This finding is important because it shows that the Canopeo app can help scientists easily and accurately assess plant growth, which can benefit agricultural research and crop development. Who this helps: This helps scientists and agricultural researchers.

PubMed

Assessing Confidence and Competence of Student Pharmacists in a Virtual Medication Adherence Training Program.

2024

American journal of pharmaceutical education

Creese M, Hale G, Benny T, Bush A, Holger DJ +8 more

Plain English
This study looked at how a virtual training program could help pharmacy students feel more confident and capable in providing medication adherence services over telehealth. After completing the program, students reported a significant increase in their confidence and skills, with their test scores improving from an average of 60% to 85%. However, they struggled with real-world patient interactions, indicating a need for better follow-up training. Who this helps: This helps pharmacy students as well as their future patients by preparing them to provide better care.

PubMed

Integrated management of cryptococcal meningitis and concurrent opportunistic infections to improve outcomes in advanced HIV disease: a randomised strategy trial.

2024

Wellcome open research

Ellis J, Nsangi L, Bangdiwala A, Hale G, Gakuru J +13 more

Plain English
This study looked at improving treatments for patients with advanced HIV who also have cryptococcal meningitis and tuberculosis (TB). Researchers tested two methods of starting TB treatment: one immediately in the hospital and another after several weeks. Out of 205 participants, they found that starting TB treatment right away could help keep more patients free of TB after 18 weeks. Who this helps: This research benefits patients with advanced HIV, especially those with cryptococcal meningitis and a risk of tuberculosis.

PubMed

Systematic Review of Prevalence of Histoplasma Antigenuria in Persons with HIV in Latin America and Africa.

2024

Emerging infectious diseases

Sekar P, Hale G, Gakuru J, Meya DB, Boulware DR +4 more

Plain English
This study looked at how common a fungal infection called histoplasmosis is among people with HIV in Latin America and Africa. Researchers found that 11% of people with HIV tested positive for histoplasmosus in their urine, rising to 13% in those with more advanced HIV. Among those showing symptoms of histoplasmosis, the prevalence was even higher at 14%. Detecting this infection early through urine tests could be very important for the health of these individuals. Who this helps: This helps patients with HIV, especially those showing symptoms of histoplasmosis.

PubMed

Mid-Upper Arm Circumference Is a Strong Predictor of Mortality Among Ugandan Adults With HIV-Associated Cryptococcal Meningitis: A Prospective Cohort Study.

2024

Open forum infectious diseases

Hale G, Adzemovic T, Huppler Hullsiek K, Mulwana S, Ndyetukira JF +15 more

Plain English
Researchers studied the relationship between arm size and survival in Ugandan adults with a serious brain infection linked to HIV. They found that those with a smaller mid-upper arm circumference (22 cm or less) had much higher death rates—62% died within 18 weeks compared to those with larger measurements. This matters because measuring arm size is an easy way to identify at-risk patients who might benefit from additional nutritional support and care. Who this helps: This benefits patients with HIV-related cryptococcal meningitis.

PubMed

Living in LALA land? Forty years of attenuating Fc effector functions.

2024

Immunological reviews

Hale G

Plain English
This study looks at how modifying the Fc region of antibodies can reduce unwanted reactions when these antibodies are used in treatments. Researchers found that, over the last 40 years, at least 45 different versions have been created to limit their binding to certain receptors, but most still have some unintended effects and can lose effectiveness. Improving these antibody modifications is crucial as new treatments, like bispecific T-cell engagers and antibody-drug conjugates, become more prominent to ensure they are both safe and effective. Who this helps: This benefits patients receiving antibody-based therapies.

PubMed

Systematic analysis of Fc mutations designed to reduce binding to Fc-gamma receptors.

2024

mAbs

Hale G, De Vos J, Davy AD, Sandra K, Wilkinson I

Plain English
This study looked at how different changes to a specific part of antibodies (called Fc) affect their ability to bind to certain receptors that can cause inflammation. The researchers created a set of similar anti-CD20 antibodies with various modifications and compared how well they worked in laboratory tests. They found that most antibody versions still had some level of activity but also showed less stability in warmer conditions compared to standard antibodies, which is important for their effectiveness and safety in treatments. Who this helps: This benefits patients using antibody therapies, especially those with conditions like cancer, where anti-CD20 antibodies are commonly used.

PubMed

Systematic analysis of Fc mutations designed to enhance binding to Fc-gamma receptors.

2024

mAbs

Hale G, Davy AD, Wilkinson I

Plain English
This study looked at different modifications of a specific part of antibodies, called the Fc region, to see how well they bind to receptors that help trigger immune responses. The researchers tested several versions of anti-CD20 antibodies and found that they performed differently in various immune activities, with some versions showing stronger effects than others. This is important because it helps identify which antibody variants may work better for treating specific conditions, leading to more effective therapies. Who this helps: This benefits patients needing more effective antibody treatments.

PubMed

Workshop summaries from the 2024 voice AI symposium, presented by the Bridge2AI-voice consortium.

2024

Frontiers in digital health

Bahr R, Anibal J, Bedrick S, Bélisle-Pipon JC, Bensoussan Y +22 more

Plain English
The 2024 Voice AI Symposium brought together experts to discuss advancements in using voice technology in healthcare. Key findings included the need for international standards in voice biomarker research and the potential for AI tools to help manage voice disorders more effectively. The discussions emphasized collaboration among researchers and healthcare providers to tackle technical and ethical challenges, driving innovation in how voice data can be used for better diagnostics and treatments. Who this helps: This benefits patients with voice disorders, healthcare providers, and researchers in the field.

PubMed

The Impact of Pharmacists on Telehealth During Transitions of Care: A Literature Review.

2023

Journal of pharmacy practice

Lopez NA, Kerelos T, Hale G

Plain English
This study reviewed how pharmacists contribute to patient care during telehealth visits when patients are transitioning from one care setting to another. It analyzed 14 studies, finding that patients who had pharmacists involved in their telehealth care experienced better health outcomes, leading to fewer hospital readmissions—reducing rates by significant margins at 30, 60, and 90 days. This matters because it demonstrates that including pharmacists in telehealth can improve patient safety and care quality, ultimately preventing unnecessary hospital stays. Who this helps: Patients transitioning between different types of care.

PubMed

External Balance Sheets and the COVID-19 Crisis.

2023

Journal of banking & finance

Hale G, Juvenal L

Plain English
This study looked at how currency values changed during the COVID-19 economic crisis and the impact on the financial health of 46 countries. It found that many emerging markets didn't suffer financial losses, even with the drop in their domestic currencies, because they saw gains from their equity investments that balanced out debt losses. In fact, for about half of the countries examined, changes in currency values made up more than 50% of the overall financial effects in 2020. Who this helps: This helps economists and policymakers understand how countries manage their finances during crises.

PubMed

Integrated Genomic and Clinicopathologic Approach Distinguishes Pancreatic Grade 3 Neuroendocrine Tumor From Neuroendocrine Carcinoma and Identifies a Subset With Molecular Overlap.

2023

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Umetsu SE, Kakar S, Basturk O, Kim GE, Chatterjee D +11 more

Plain English
This study looked at different types of pancreatic tumors that are hard to categorize, specifically grade 3 pancreatic neuroendocrine tumors (G3 PanNET) and neuroendocrine carcinomas (PanNEC). Researchers analyzed 47 tumor samples and found that by using a combination of genetic testing and specific staining methods, they could accurately diagnose 89% of the cases, identifying 17 as G3 PanNETs and 17 as PanNECs. This is important because understanding the exact type of tumor influences treatment choices and patient outcomes. Who this helps: This benefits patients with pancreatic tumors by ensuring they receive the most appropriate treatment for their specific type of tumor.

PubMed

Development of a brief menstrual quality of life measure for women with heavy menstrual bleeding.

2023

BMC women's health

Lancastle D, Kopp Kallner H, Hale G, Wood B, Ashcroft L +1 more

Plain English
Researchers created a new tool called PERIOD-QOL to help women with heavy menstrual bleeding (HMB) understand how their condition affects their quality of life. In a study with 376 women, those with HMB scored significantly lower on quality of life measures compared to those with lighter periods, showing that heavy bleeding has a major negative impact. This is important because it can encourage women to seek help and raise awareness about the effects of HMB. Who this helps: This helps women suffering from heavy menstrual bleeding.

PubMed

Research needs for a food system transition.

2023

Climatic change

McDermid SS, Hayek M, Jamieson DW, Hale G, Kanter D

Plain English
This study looked at how animal agriculture is harming the environment and public health and called for a shift toward more plant-based foods. Researchers found that animal farming contributes significantly to climate change and health problems, while also leading to the killing of trillions of animals each year. To address these issues, they recommend a detailed research plan that includes collecting data on these food systems and evaluating potential benefits and trade-offs from moving towards plant-based alternatives. Who this helps: This benefits patients, the environment, and policymakers.

PubMed

Don't ignore perimenopause.

2023

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Prior JC, Hitchcock CL, Shirin S, Hale G, Goshtasebi A

PubMed

Incidence of retained biopsy specimens after esophagogastroduodenoscopy and colonoscopy.

2023

Endoscopy international open

Toy G, Colletier K, Hale G, Valentine J, Gawron AJ +4 more

Plain English
This study looked at how often tissue samples taken during gastrointestinal procedures, like endoscopies and colonoscopies, are accidentally left behind in the instruments used. Out of 105 procedures where biopsies were taken, nearly half (48%) had retained samples, with 58% during endoscopies compared to 36% during colonoscopies. This finding is important because these leftover tissues could affect patient diagnoses and treatment plans, highlighting the need for better monitoring and prevention methods. Who this helps: This benefits patients by ensuring more accurate diagnoses and safer procedures.

PubMed

Flexibility in assessment of rare disease technologies via NICE's single technology appraisal route: a thematic analysis.

2023

Journal of comparative effectiveness research

Hale G, Morris J, Barker-Yip J

Plain English
This study looked at how the UK’s health technology assessment body, NICE, evaluates treatments for rare diseases compared to more common ones. It found that while NICE does show some flexibility in assessing rare disease treatments—like handling uncertainty and negotiating commercial agreements—these treatments often face longer evaluation times, averaging a few months more than non-rare diseases. This matters because these delays can impede patients' access to crucial medications. Who this helps: Patients with rare diseases who need timely access to effective treatments.

PubMed

Impact of Student Pharmacist-Led Transition-of-Care Services on 30-Day Hospital Readmissions at a University Call Center.

2023

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians

Pham H, Gangoo-Dookhan T, Hale G, Perez A, Joseph T

Plain English
This study looked at how phone calls from pharmacy students to patients after hospital discharge affected the number of people who had to go back to the hospital within 30 days. Out of 84 patients, those who received calls had a lower readmission rate related to their original health problems (5.9%) compared to those who didn’t get a call (11.1%). This is important because reducing readmissions can save healthcare costs and improve patient care. Who this helps: This helps patients by reducing the chances of going back to the hospital too soon after leaving.

PubMed

Sustained Effect of Clinical Decision Support for Heart Failure: A Natural Experiment Using Implementation Science.

2023

Applied clinical informatics

Trinkley KE, Wright G, Allen LA, Bennett TD, Glasgow RE +12 more

Plain English
This study looked at how well a new, personalized clinical decision support (CDS) system for prescribing heart failure medication—a specific type of heart medication called beta blockers—works in real-world settings compared to a standard commercial version. Researchers found that the new system led to a 26.1% increase in appropriate prescriptions compared to the old system, and that doctors were much more likely to use it (81% versus just 29% for the commercial system). This is important because better prescribing can lead to improved heart failure management and healthier patients. Who this helps: This helps patients with heart failure and their doctors by ensuring they receive better treatment recommendations.

PubMed

Utilizing Pharmacist-Led Telehealth Services in Ambulatory Patients with Heart Failure.

2023

Innovations in pharmacy

Lugo Zamora IL, Lloyd C, Lorenzo-Castro S, Mussenden C, Hale G

Plain English
This study looked at how telehealth services led by pharmacists can help adults with heart failure manage their condition. Out of 37 patients who had a telehealth visit with a pharmacist, only 2 were hospitalized for heart failure afterwards, and 15 had cardiovascular-related hospitalizations. This is significant because it shows that pharmacist support can reduce the need for hospital visits, which can improve patient well-being and lower healthcare costs. Who this helps: This benefits patients with heart failure.

PubMed

Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease.

2022

Transplantation and cellular therapy

Shah NC, Bhoopatiraju S, Abraham A, Anderson E, Andreansky M +13 more

Plain English
This study looked at the safety of a treatment called G-CSF in patients with sickle cell disease who underwent a type of bone marrow transplant. Researchers found that G-CSF helped patients recover their white blood cell count, called neutrophils, in a median of 13 days without causing any sickle cell-related complications. The results are important because they show that G-CSF can be safely used after transplant, potentially improving recovery times for these patients. Who this helps: This helps patients with sickle cell disease undergoing bone marrow transplants.

PubMed

Dry-compression packing of hydroxyapatite nanoparticles within a flat cuboid chromatography device and its use for fast protein separation.

2022

Journal of chromatography. A

Ghosh R, Hale G, Durocher Y, Gatt P

Plain English
This study looked at a new method for quickly separating proteins using a specially designed device filled with tiny particles called hydroxyapatite nanoparticles. Researchers found that proteins could be separated in about one minute, and increasing the flow rate improved both the amount and purity of the proteins collected. This advancement matters because it allows for faster and more cost-effective protein separation, which is important for various medical and research applications. Who this helps: This helps patients who benefit from faster access to therapeutic proteins, as well as researchers and doctors working with protein-based treatments.

PubMed

Harnessing the Power of Purple Sweet Potato Color and-Inositol to Treat Classic Galactosemia.

2022

International journal of molecular sciences

Hagen-Lillevik S, Johnson J, Siddiqi A, Persinger J, Hale G +1 more

Plain English
This study examined how two safe supplements, purple sweet potato color and inositol, can help treat classic galactosemia, a serious metabolic disorder that causes various health problems, including brain and growth issues. The researchers found that purple sweet potato color improved ovary, brain, and liver functions in mouse models of the disease, while inositol showed benefits in the ovary and brain as well. These findings are important because they suggest new treatment options for a condition that currently has no effective therapies beyond diet changes. Who this helps: This helps patients with classic galactosemia and their families.

PubMed

Systematic analysis of the varied designs of 819 therapeutic antibodies and Fc fusion proteins assigned international nonproprietary names.

2022

mAbs

Wilkinson I, Hale G

Plain English
This research analyzed the designs of 819 therapeutic antibodies and related proteins to understand how they are structured and used. The study found 57 different molecular formats and around 90 variations in their constant regions, which play a key role in their function. This information is important because it helps researchers identify which designs are most effective and how they can continue to improve future antibody therapies. Who this helps: This benefits researchers and developers of new antibody treatments.

PubMed

Considerations of management and marketing courses within pharmacy curricula in the United States.

2022

Currents in pharmacy teaching & learning

Khanfar NM, Harrington CA, Alsharif NZ, Warravat A, Hale G

Plain English
This study looked at how many pharmacy programs in the United States include courses on management and marketing. Out of 134 top pharmacy schools, 36 (27%) did not offer any management courses, and 101 (75%) had no marketing courses. Only 25% of the schools provided a marketing course, with most being optional rather than required. This is important because pharmacists need business skills to thrive in their careers, and many programs are falling short in preparing students for those challenges. Who this helps: This helps pharmacy students and future pharmacists.

PubMed

Destigmatizing public health concerns and supply of COVID-19 vaccines.

2021

Health marketing quarterly

Akel S, Bleibel F, Hale G, Khanfar NM

Plain English
This study looked at people's fears and concerns about the COVID-19 vaccine, focusing on issues like ingredients, speed of development, and distribution plans. It highlighted the importance of addressing these worries to reduce hesitancy around getting vaccinated, emphasizing fair distribution of the vaccine both in the U.S. and globally. Vaccination is crucial for ending the pandemic and returning to normal life, which matters because it will save lives and improve public health. Who this helps: This helps patients, especially those hesitant about getting vaccinated, as well as healthcare providers involved in vaccination efforts.

PubMed

Cutaneous Kaposi's sarcoma in an HIV-negative patient with Crohn's disease on thiopurine immunosuppression.

2021

BMJ case reports

Colbert RD, Gaya D, Hale G, Rickaby W

Plain English
This medical study looked at a 61-year-old man with Crohn's disease who developed a type of skin cancer called cutaneous Kaposi's sarcoma after using a medication for immune suppression. The researchers found that it is generally advised to stop such medications when this cancer appears; however, in this case, the patient's skin lesion was surgically removed, and the immune-suppressing treatment was continued afterward. This is significant because it highlights a unique approach to managing a rare condition in a patient who is usually considered at high risk for complications. Who this helps: This helps doctors and patients with Crohn's disease and similar conditions making treatment decisions.

PubMed

Effects of a Therapeutic Interchange Between Branded and Generic Inhaled Therapy on Chronic Obstructive Pulmonary Disease.

2021

The Senior care pharmacist

Acharya RB, Joseph T, Moreau C, Hale G, Perez A +1 more

Plain English
The study looked at what happens when patients with chronic obstructive pulmonary disease (COPD) switch from branded inhalers to a generic version. Researchers found that 45.5% of patients using the generic inhalers had a COPD flare-up, compared to only 18.2% with the branded inhalers. This is significant because it indicates that switching to the generic inhalers could lead to more health issues for patients. Who this helps: This information is important for patients with COPD and their doctors when considering inhaler prescriptions.

PubMed

Evaluating the Effects of Symptom Monitoring on Menopausal Health Outcomes: A Systematic Review and Meta-Analysis.

2021

Frontiers in global women's health

Andrews R, Hale G, John B, Lancastle D

Plain English
This study looked at how keeping track of menopausal symptoms can affect women's health. The findings showed that using symptom diaries led to significant improvements, especially in reducing hot flashes, with a large effect size of 0.73, meaning these tools helped a lot in managing symptoms. This is important because it highlights that monitoring symptoms can enhance communication with doctors and support better treatment planning for menopausal women. Who this helps: This helps menopausal women seeking relief from their symptoms.

PubMed

Fc-engineered antibodies with immune effector functions completely abolished.

2021

PloS one

Wilkinson I, Anderson S, Fry J, Julien LA, Neville D +3 more

Plain English
This study focused on creating new types of antibodies that do not trigger unwanted inflammation by completely blocking their interaction with certain immune receptors. The researchers developed variants of antibodies with specific changes in their structure, resulting in zero binding to these receptors and no inflammatory responses. This is important because it could lead to safer and more effective treatments for various diseases. Who this helps: This benefits patients receiving antibody-based therapies.

PubMed

Frequent Co-Authors

Jayne Ellis Alexandra Perez David B Meya David R Boulware Asmus Tukundane Jane Gakuru Ian Wilkinson Mable Kabahubya Nathan C Bahr Enock Kagimu

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.